On May 5, 2025, China SXT Pharmaceuticals, Inc. entered into a securities purchase agreement to issue 200,000 ordinary shares, raising approximately $100,000, with the transaction closing on May 12, 2025. As of May 12, 2025, the company has issued a total of 16,027,758 ordinary shares.